The GLP-1
Semaglutide · Injection
A long-acting GLP-1 receptor agonist studied for appetite suppression, blood sugar control, and clinically significant weight loss.
All doses $199 / mo
Benefits.
- Studied for ~14.9% body-weight reduction at 68 weeks (STEP-1 trial)
- Reduces fasting glucose and improves HbA1c (SUSTAIN trial program)
- Explored for cardiovascular protection (SELECT — 20% MACE reduction)
- May reduce inflammation markers (hs-CRP)
- Slows gastric emptying for sustained satiety
How it works.
Step 01
Semaglutide is a long-acting synthetic GLP-1 receptor agonist.
Step 02
It binds GLP-1 receptors in the pancreas, stomach, and brain.
Step 03
Slows gastric emptying — food stays in the stomach longer, creating fullness.
Step 04
Acts on hypothalamic appetite centers to reduce hunger signals.
For educational reference only — not medical advice. Loop does not diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA. Your protocol is built with a licensed Loop clinician based on your goals, history, and labs.